Skip to main content
. 2022 Feb 15;28(11):1725–1736. doi: 10.1093/ibd/izab357

Table 3.

Multivariate analysis of factors associated with ustekinumab discontinuation

Factor HR 95% CI
Previous abdominal surgery (yes vs no) 2.14 1.47-3.18
Concomitant steroid treatment (yes vs no) 1.82 1.24-2.67
Maintenance schedule (every 8 wk vs every 12 wk) 0.26 0.08-0.81

Abbreviations: CI, confidence interval; HR, hazard ratio.